Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Apnimed Inc.
Headquarters: Cambridge, MA, United States of America
Website: https://apnimed.com/
Year Founded: 2017
Status: Private
BioCentury | Oct 25, 2024
Management Tracks
Chinook veterans join Jade
Plus: Apnimed hires Ramzi Benamar as CFO and an update from PhotonPharma
BioCentury | Jan 24, 2024
Management Tracks
Markison to succeed Heino as Lantheus CEO
Plus: Lisa Olson becomes CEO of Enthera, and updates from Bayer, Neumora, PDS and more
BioCentury | Jan 4, 2023
Deals
Jan. 3 Quick Takes: Gilead, Evoq in lymphatic delivery deal
Plus: Vera dips on postmarket readout and updates from ArriVent, Apnimed, CStone, Legend and more
BioCentury | Oct 18, 2022
Deals
Oct. 17 Quick Takes: Gilead, MacroGenics in deal for bispecific
Biogen’s ALS candidate delayed, plus updates from Oculis, Treeline, Minerva, Acrivon and more
BioCentury | Oct 6, 2022
Management Tracks
J&J’s Kumar becomes Cure’s CEO
Plus Shanton recruits LianBio’s Li and updates from BlueSphere, Valence and Apnimed
BioCentury | May 5, 2022
Regulation
May 4 Quick Takes: FDA clears Fujirebio’s Alzheimer’s diagnostic
Plus Jazz licenses sleep disorder therapy from Sumitomo and updates from Apnimed, Phathom, AZ, Kezar
BioCentury | Sep 28, 2021
Management Tracks
Peng joins Denali as chief commercial officer
Plus: Twist, Vaxart, Insilico, Gilde, Panakes and more
BioCentury | Mar 26, 2021
Finance
March 25 Quick Takes: Lava flows down on first day after $100.5M IPO; plus Scipher, Eliem, Brii, Bioheng, RiverVest, JSR Life Science and Apnimed
Lava dips on first day after raising $100.5M IPOLava Therapeutics B.V. (NASDAQ:LVTX) fell $0.70 to $14.30 in its first day of trading on NASDAQ after raising $100.5 million through the sale of 6.7
BioCentury | Nov 12, 2020
Management Tracks
ObsEva, Korro bring in new CEOs; plus Cerebral, Spartan, Apnimed and Micronoma
Women’s reproductive health company ObsEva S.A. (SIX:OBSN; NASDAQ:OBSV) hired Brian O’Callaghan as CEO , effective Dec. 1. He succeeds Ernest Loumaye, who will
Items per page:
1 - 10 of 10